secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLESENCE, INC. (SLSN)
CIK:        0000883107
Form:       8-K
Filed at:   2024-04-11T23:59:59+00:00
Accession:  0001171843-24-001961
Event type: litigation
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nanophase settles BASF exclusivity litigation, amends supply agreement
----------------------------------------------------------------------

- Mutual release of all claims in BASF v. Nanophase (NJ Super. Ct. MRS-L-1396-22); case dismissed with prejudice.
- Amendment No. 5 clarifies exclusivity: BASF retains field exclusivity for zinc oxide, but Nanophase and Solésence can sell finished products and certain dispersions.
- Binding MOU commits Nanophase to develop a modified zinc oxide product for BASF's exclusive purchase (commercially reasonable efforts).
- Parties covenant not to sue on settled claims, agree to non-disparagement and confidentiality (subject to SEC disclosure).
- Management expects continued growth in API and Solésence finished products with legal uncertainty resolved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883107/000117184324001961/0001171843-24-001961-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883107/000117184324001961/f8k_041124.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-001961

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer